Clinical Trial Update: GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM [Phase 4]

View source ↗

Summary

A Phase 4 clinical study is investigating the effects of GLP-1 receptor agonists on inflammatory and endothelial biomarkers in adults with type 2 diabetes melli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Federico II University | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 4 | Status: RECRUITING